Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors-Reference-Cited by-同舟云学术

Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors

Published:2021-08 Issue: Volume:161 Page:198-204
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Meillan Nicolas^ORCID,Orthuon Alexandre,Chauchat Paul,Atlani David^ORCID,Bouche Olivier,Chaulin Bertrand,David Céline,Deberne Mélanie,Debrigode Charles,Kao William,Keller Audrey,Laharie Hortense,Lamezec Bruno,Lemanski Claire,Magné Nicolas,Mahé Marc-André,Mere Pascale,Moureau-Zabotto Laurence,Peiffert Didier,Pointreau Yoann,Quéro Laurent,Racadot Séverine,Roca Sophie,Sargos Paul,Servagi Stéphanie,Tang Eliane,Vendrely Véronique,Doyen Jérôme,Huguet Florence

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference47 articles.

1. Recurrence and survival after total mesorectal excision for rectal cancer;Heald;The Lancet,1986

2. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma;Marsh;Dis Colon Rectum,1994

3. Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate;Folkesson;J Clin Oncol,2005

4. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group;Cedermark;Cancer,1995

5. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001;92:896–902.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Executive Summary of the American Radium Society on Appropriate Use Criteria for Nonoperative Management of Rectal Adenocarcinoma: Systematic Review and Guidelines;International Journal of Radiation Oncology*Biology*Physics;2024-05

2. Excluding external iliac node irradiation during neoadjuvant radiotherapy decreases lower intestinal toxicity without compromising efficacy in T4b rectal cancer patients with tumours involving the anterior structures;Discover Oncology;2024-03-16

3. Excluding external iliac node irradiation during neoadjuvant radiotherapy decreases lower intestinal toxicity without compromising efficacy in T4b rectal cancer patients with tumours involving the anterior structures;2023-03-27